References
- Yeoh M. Investigation and management of an ovarian mass. Aust Fam Physician. 2015;44:48–52.
- Alborzi S, Momtahan M, Parsanezhad ME, et al. A prospective, randomized study comparing laparoscopic ovarian cystectomy versus fenestration and coagulation in patients with endometriomas. Fertil Steril. 2004;82:1633–1637.
- Beretta P, Franchi M, Ghezzi F, et al. Randomized clinical trial of two laparoscopic treatments of endometriomas: cystectomy versus drainage and coagulation. Fertil Steril. 1998;70:1176–1180.
- Hart R, Hickey M, Maouris P, et al. Excisional surgery versus ablative surgery for ovarian endometriomata: a cochrane review. Hum. 2005;20:3000–3007.
- Chang HJ, Han SH, Lee JR, et al. Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Müllerian hormone levels. Fertil Steril. 2010;94:343–349.
- Raffi F, Metwally M, Amer S, et al. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97:3146–3154.
- Kwon SK, Kim SH, Yun SC, et al. Decline of serum anti-Müllerian hormone levels after laparoscopic ovarian cystectomy in endometrioma and other benign cysts; a prospective cohort study. Fertil Steril. 2014;101:435–441.
- Ergun B, Ozsurmeli M, Dundar O, et al. Changes in markers of ovarian reserve after laparoscopic ovarian cystectomy. J Minim Invasive Gynecol. 2015;22:997–1003.
- Busacca M, Vignali M. Endometrioma excision and ovarian reserve: a dangerous relation. J Minim Invasive Gynecol. 2009;16:142–148.
- Somigliana E, Berlanda N, Benaglia L, et al. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum anti-Müllerian hormone level modifications. Fertil Steril. 2012;98:1531–1538.
- Lind T, Hammarström M, Lampic C, et al. Anti-Müllerian hormone reduction after ovarian cyst surgery is dependent on the histological cyst type and preoperative anti-Müllerian hormone levels. Acta Obstet Gynecol Scand. 2015;94:183–190.
- Smeenk JM, Sweep FC, Zielhuis GA, et al. Anti-Müllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection. Fertil Steril. 2007;87:223–226.
- Steiner AZ, Pritchard D, Stanczyk FZ, et al. Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. JAMA. 2017;318:1367–1376.
- Baldi A, Campioni M, Signorile PG. Endometriosis: pathogenesis, diagnosis, therapy and association with cancer (review). Oncol Rep. 2008;19:843–846.
- Alammari R, Lightfoot M, Hur HC. Impact of cystectomy on ovarian reserve: review of the literature. J Minim Invasive Gynecol. 2017;24:247–257.
- Ferraretti AP, La Marca A, Fauser BC, et al. ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the bologna criteria. Hum Reprod. 2011;26:1616–1624.
- Ding Y, Yuan Y, Ding J, et al. Comprehensive assessment of the impact of laparoscopic ovarian cystectomy on ovarian reserve. J Minim Invasive Gynecol. 2015;22:1252–1259.
- Vignali M, Mabrouk M, Ciocca E, et al. Surgical excision of ovarian endometriomas: does it truly impair ovarian reserve? Long term anti-Müllerian hormone (AMH) changes after surgery. J Obstet Gynaecol Res. 2015;41:1773–1778.
- Iliodromiti S, Kelsey TW, Wu O, et al. The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature. Hum Reprod Update. 2014;20:560–570.
- Seifer DB, Tal O, Wantman E, et al. Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum anti-Müllerian hormone: a multivariate analysis of over 5000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012–2013. Fertil Steril. 2016;105:385–393.
- Lee TH, Liu CH, Huang CC, et al. Serum antiMüllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod. 2008;23:160–167.
- La Marca A, Sighinolfi G, Radi D, et al. Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16:113–130.
- Salmassi A, Mettler L, Hedderich J, et al. Cut-off levels of anti-Müllerian hormone for the prediction of ovarian response, in vitro fertilization outcome and ovarian hyperstimulation syndrome. Int J Fertil Steril. 2015;9:157–167.
- Casadei L, Manicuti C, Puca F, et al. Can anti-Müllerian hormone be predictive of spontaneous onset of pregnancy in women with unexplained infertility? J Obstet Gynaecol. 2013;33:857–861.
- La Marca A, Spada E, Grisendi V, et al. Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history. Eur J Obstet Gynecol Reprod Biol. 2012;163:180–184.
- Lind T, Lampic C, Olofsson JI, et al. Postoperative AMH reduction is not associated with reduced fecundity two years following ovarian cyst surgery. Gynecol Endocrinol. 2016;32:745–748.